Cosmos Health (COSM) Net Margin (2014 - 2026)
Cosmos Health (COSM) recorded quarterly Net Margin of 15.65% in Q1 2026, down 175.57% on a QoQ basis from 20.71% in Q4 2025, and down 968.0% year-over-year from 1.8% in Q1 2025.
Cosmos Health (COSM) Net Margin (2014 - 2026) Analysis & Trends
Cosmos Health has disclosed Net Margin across 12 years of filings, most recently posting 15.65% for Q1 2026.
- Quarterly Net Margin fell 968.0% year-over-year to 15.65% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 339.3% (down 29947.0% YoY) and the FY2025 annual result came in at 1126.18%, down 108506.0% from the prior year.
- Net Margin fell to 15.65% in Q1 2026, from 20.71% in the prior quarter.
- Over five years, Net Margin peaked at 20.71% in Q4 2025 and troughed at 316.18% in Q4 2022.
- A 5-year average of 53.09% and a median of 19.62% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin slumped 25990 bps — and 2023, when it surged 18374 bps.
- Tracing COSM's Net Margin over 5 years: stood at 316.18% in 2022, then surged by 58 bps to 132.44% in 2023, then soared by 49 bps to 67.09% in 2024, then surged by 131 bps to 20.71% in 2025, then slumped by 176 bps to 15.65% in 2026.
- Business Quant data shows COSM's Net Margin at 15.65% in Q1 2026, 20.71% in Q4 2025, and 31.28% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 1.93% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 2.08% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 0.62% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -16.06% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -50.99% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.58% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -15.65% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.65% |
| Dec 31, 2025 | 20.71% |
| Sep 30, 2025 | -31.28% |
| Jun 30, 2025 | -19.18% |
| Mar 31, 2025 | -5.97% |
| Dec 31, 2024 | -67.09% |
| Sep 30, 2024 | -67.50% |
| Jun 30, 2024 | -19.62% |
| Mar 31, 2024 | -12.80% |
| Dec 31, 2023 | -132.44% |
| Sep 30, 2023 | -26.23% |
| Jun 30, 2023 | -7.94% |
| Mar 31, 2023 | -3.72% |
| Dec 31, 2022 | -316.18% |
| Sep 30, 2022 | -16.58% |
| Jun 30, 2022 | -138.27% |
| Mar 31, 2022 | -42.73% |
| Dec 31, 2021 | -56.28% |
| Sep 30, 2021 | -14.24% |
| Jun 30, 2021 | -16.02% |